Motonari UESUGI,Salih J. Wakil,Lutfi ABU-ELHEIGA,Qian MAO,Shinji KAMISUKI,Akira KUGIMIYA,Mizuki WATANABE
申请号：
US15803655
公开号：
US20180291013A1
申请日:
2017.11.03
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to treatment and/or prevention of one or more metabolic disorders utilizing fatostatin A and/or a derivative and/or analog thereof. In other aspects, the compound for treatment and/or prevention of one or more metabolic disorders utilizes an A-B-C tripartite structure, wherein A, B, and C are identical or non-identical structures and are described in detail herein. In specific aspects, the metabolic disorder includes obesity or diabetes, for example.
